Literature DB >> 29175536

Stomach reduction or gastric bypass as risk factor for treatment failure after DAA therapy for hepatitis C?

Katharina L Hupa1, Katja Deterding1, Kerstin Port1, Markus Kimmann1, Michael P Manns2, Heiner Wedemeyer1, Markus Cornberg3.   

Abstract

Entities:  

Keywords:  Direct acting antivirals; Gastric surgery; Hepatitis C; Treatment failure

Mesh:

Year:  2017        PMID: 29175536     DOI: 10.1016/j.jhep.2017.10.035

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  1 in total

1.  Transjugular Intrahepatic Portosystemic Shunt: A Possible Risk Factor for Direct-Acting Antiviral Treatment Failure in Patients With Hepatitis C?

Authors:  Felix Piecha; Jan-Michael Gänßler; Sabine Jordan; Can Ergen; Harald Ittrich; Johannes Kluwe; Sven Pischke; Ansgar W Lohse; Julian Schulze Zur Wiesch
Journal:  Hepatol Commun       Date:  2019-03-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.